XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Interim Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Cash flows used in operating activities:        
Net loss $ (8,745) $ 745 $ (51,817) $ (11,154)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization     11,061 9,364
Amortization of deferred charges     171 234
Share of loss from joint ventures   (38) 2,667 175
Net loss attributable to non-controlling interest (387)   (701)  
Interest expense 982 620 2,330 1,959
Interest income (60) (50) (129) (99)
Interest paid on long-term debt     (2,989) (2,926)
Unrealized foreign exchange gain/loss     77 19
Impairments     29,799  
Write-off of joint venture loan   592  
(Gain) loss on disposal of assets (7) (7) 40
Non-cash lease expense     775 (376)
Share-based compensation     3,004 5,705
Deferred income taxes     (19,670) (3,196)
Changes in non-cash working capital items     11,621 (20,851)
Net cash used in operating activities     (13,216) (21,106)
Cash flows used in investing activities:        
Purchases of property, plant and equipment     (12,869) (15,131)
Acquisitions, net     (4,693) (25,944)
Advances to joint ventures       (15)
Notes receivable     (1,914) (1,109)
Net cash used in investing activities     (19,476) (42,199)
Cash flows (used in) provided by financing activities:        
Proceeds from borrowings     4,000 4,147
Repayments on borrowings     (6,262) (7,410)
Proceeds from issuance of common stock and warrants     824 135,000
Issuance costs       (7,511)
Proceeds from exercise of stock options     192 199
Proceeds from exercise of warrants       18,495
Share repurchases       (5,000)
Payments on capital lease obligations 0 (227) (782) (537)
Payment of note payable related to acquisition       (15,498)
Net cash (used in) provided by financing activities     (2,028) 121,885
Effect of exchange rate changes on cash and cash equivalents     (782) 191
Net (decrease) increase in cash and cash equivalents     (35,502) 58,771
Cash and cash equivalents, beginning of period     58,667 25,679
Cash and cash equivalents, end of period $ 23,165 $ 84,450 $ 23,165 84,450
Supplemental disclosure of non-cash activities:        
Shares issued for acquisition       $ 41,752